GSA Capital Partners’s Select Medical SEM Stock Holding History

GSA Capital Partners’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	83,665 +29,947	+56%	+$493K	0.09%	326
2026 Q1	$875K	Buy	+53,718	New	+$841K	0.05%	557
2025 Q4	–	Sell	-19,889	Closed	-$255K	–	2051
2025 Q3	$255K	Sell	19,889 -297	-1%	-$3.96K	0.02%	1294
2025 Q2	$306K	Sell	20,186 -15,779	-44%	-$246K	0.02%	1242
2025 Q1	$601K	Buy	+35,965	New	+$662K	0.05%	668
2022 Q4	–	Sell	-46,103	Closed	-$549K	–	1840
2022 Q3	$549K	Buy	+46,103	New	+$655K	0.07%	501
2022 Q2	–	Sell	-78,674	Closed	-$1.02M	–	1756
2022 Q1	$1.02M	Buy	78,674 +16,041	+26%	+$212K	0.14%	175
2021 Q4	$992K	Buy	+62,633	New	+$1.07M	0.12%	207
2020 Q1	–	Sell	-120,690	Closed	-$1.52M	–	1501
2019 Q4	$1.52M	Buy	120,690 +46,411	+62%	+$500K	0.18%	67
2019 Q3	$663K	Sell	74,279 -17,461	-19%	-$153K	0.09%	372
2019 Q2	$784K	Buy	91,740 +29,586	+48%	+$234K	0.09%	372
2019 Q1	$472K	Buy	+62,154	New	+$500K	0.05%	728
2018 Q4	–	Sell	-59,622	Closed	-$591K	–	1698
2018 Q3	$591K	Sell	59,622 -52,655	-47%	-$545K	0.03%	989
2018 Q2	$1.1M	Sell	112,277 -195,275	-63%	-$1.92M	0.05%	698
2018 Q1	$2.86M	Buy	307,552 +227,616	+285%	+$2.17M	0.15%	131
2017 Q4	$760K	Buy	+79,936	New	+$764K	0.05%	729
2016 Q3	–	Sell	-65,899	Closed	-$386K	–	1944
2016 Q2	$386K	Buy	+65,899	New	+$437K	0.02%	1235
2015 Q4	–	Sell	-166,971	Closed	-$971K	–	1946
2015 Q3	$971K	Sell	166,971 -97,518	-37%	-$723K	0.05%	660
2015 Q2	$2.31M	Buy	264,489 +158,394	+149%	+$1.33M	0.09%	281
2015 Q1	$848K	Buy	106,095 +38,229	+56%	+$286K	0.03%	1001
2014 Q4	$527K	Sell	67,866 -164,282	-71%	-$1.2M	0.04%	897
2014 Q3	$1.5M	Buy	+232,148	New	+$1.79M	0.08%	292

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

GSA Capital Partners's SEM Position: Q2 2026 in Review

GSA Capital Partners increased its Select Medical (SEM) stake by 56% in Q2 2026, buying an estimated $493K and bringing the position to 83,665 shares worth $1.38M. The position accounts for 0.09% of the portfolio, ranked #326.

GSA Capital Partners first reported a position in SEM in Q3 2014 and has held it in 22 quarters since. The position peaked at $2.86M in Q1 2018. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

GSA Capital Partners held 83,665 shares of Select Medical worth $1.38M as of Q2 2026.
GSA Capital Partners bought 29,947 Select Medical shares in Q2 2026, an estimated $493K.
Select Medical made up 0.09% of GSA Capital Partners's portfolio in Q2 2026, its #326 holding.
GSA Capital Partners first reported a position in Select Medical in Q3 2014 and has held it in 22 quarters since.
GSA Capital Partners's Select Medical position peaked at $2.86M in Q1 2018.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.